Abstract：
BACKGROUND:Pemphigus vulgaris (PV) is an autoimmune blistering disease of the skin and mucous membranes. Genital involvement occurs when most other common sites are concurrently affected or are in remission. Systemic lupus erythematosus (SLE) is an autoimmune disease that may affect many parts of the body and the skin with occasional bullous lesions. Pemphigus vulgaris and SLE may be associated, albeit rarely. Here, we report the first case of a woman affected with SLE presenting with early invasive squamous cell carcinoma (SCC) arising from Pemphigus Vulgaris of the vulva. CASE PRESENTATION:A 27-year-old Caucasian woman was admitted to our Gynaecology Unit for bleeding vegetant lesions of the vulva. Her history was characterized by systemic lupus erythematosus and PV. Biopsy showed concomitant PV and vulvar intraepithelial neoplasia (VIN) grade 3. One month later a new biopsy revealed progression from VIN 3 to early SCC. Despite chemotherapy, no remission of disease was observed. She died six months after diagnosis CONCLUSION:Our case underlines PV as another chronic inflammatory disease of the lower genital tract predisposing to VIN-SCC. It suggests the need for careful follow-up of patients with chronic inflammatory disease, especially when concomitant autoimmune disorders are present. Moreover, a biopsy should be always performed if there are PV lesions because of the possibility of neoplastic disease.
journal_name
BMC Cancerjournal_title
BMC cancerauthors
Bifulco G,Mandato VD,Piccoli R,Giampaolino P,Mignogna C,Mignogna MD,Costagliola L,Nappi Cdoi
10.1186/1471-2407-10-324subject
Has Abstractpub_date
2010-06-23 00:00:00pages
324issn
1471-2407pii
1471-2407-10-324journal_volume
10pub_type
杂志文章相关文献
BMC CANCER文献大全abstract：BACKGROUND:FOXM1 regulates expression of cell cycle related genes that are essential for progression into DNA replication and mitosis. Consistent with its role in proliferation, elevated expression of FOXM1 has been reported in a variety of human tumour entities. FOXM1 is a gene of interest because recently chemical in...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-8-42
更新日期：2008-02-06 00:00:00
abstract：BACKGROUND:The EphB4 receptor tyrosine kinase has been reported as increased in tumours originating from several different tissues and its expression in a prostate cancer xenograft model has been reported. METHODS:RT-PCR, western blotting and immunohistochemical techniques were used to examine EphB4 expression and pro...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-5-119
更新日期：2005-09-20 00:00:00
abstract：BACKGROUND:Breast cancer is the second leading cause of cancer deaths in women in the United States. Although the causes of this disease are incompletely understood, oxidative DNA damage is presumed to play a critical role in breast carcinogenesis. A common oxidatively induced DNA lesion is 8-hydroxyguanine (8-OH-Gua),...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-6-297
更新日期：2006-12-27 00:00:00
abstract：BACKGROUND:HAX-1 has been described as a protein potentially involved in carcinogenesis and especially metastasis. Its involvement in regulation of apoptosis and cell migration along with some data indicating its overexpression in cancer cell lines and tumors suggests that HAX-1 may play a role in neoplastic transforma...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-10-76
更新日期：2010-03-02 00:00:00
abstract：BACKGROUND:One of the basic prerequisites for generating evidence-based data is the availability of classification systems. Attempts to date to classify breast cancer operations have focussed on specific problems, e.g. the avoidance of secondary corrective surgery for surgical defects, rather than taking a generic appr...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-9-108
更新日期：2009-04-08 00:00:00
abstract：BACKGROUND:The goal of this exploratory study was to develop and assess a prediction model which can potentially be used as a biomarker of breast cancer, based on anthropometric data and parameters which can be gathered in routine blood analysis. METHODS:For each of the 166 participants several clinical features were ...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-017-3877-1
更新日期：2018-01-04 00:00:00
abstract：BACKGROUND:Oncolytic viruses, including vaccinia virus (VACV), are a promising alternative to classical mono-cancer treatment methods such as surgery, chemo- or radiotherapy. However, combined therapeutic modalities may be more effective than mono-therapies. In this study, we enhanced the effectiveness of oncolytic vir...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-12-366
更新日期：2012-08-23 00:00:00
abstract：BACKGROUND:Recurrent/metastatic squamous cell carcinoma of the head and neck (SCCHN) has a poor prognosis and the combination of cisplatin and cetuximab, with or without 5-fluorouracil, is the gold standard treatment in this stage. Thus, the concomitant use of novel compounds represents a critical strategy to improve t...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-016-2957-y
更新日期：2016-11-25 00:00:00
abstract：BACKGROUND:Previous studies have found that polymorphisms of the DNA repair gene X-ray repair cross-complementing group 1(XRCC1) and environmental factors are both associated with an increased risk of stomach cancer, but no study has reported on the potential additive effect of these factors among Thai people. The aim ...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-017-3675-9
更新日期：2017-10-11 00:00:00
abstract：BACKGROUND:The EGFR-T790M mutation is clinically detected using re-biopsy in approximately 50% of patients with acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in advanced non-small cell lung cancer (NSCLC) who harbor EGFR mutations. However, little is known about the popu...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-018-5153-4
更新日期：2018-12-11 00:00:00
abstract：BACKGROUND:Bevacizumab, an antibody neutralizing Vascular Endothelial Growth Factor (VEGF), is licensed for the management of patients with advanced colon cancer. However, tumor biomarkers identifying the molecular tumor subsets most amenable to angiogenesis modulation are lacking. METHODS:We profiled expession of 245...
journal_title：BMC cancer
pub_type： 杂志文章,多中心研究
doi：10.1186/1471-2407-14-111
更新日期：2014-02-20 00:00:00
abstract：BACKGROUND:Neoadjuvant Chemotherapy (NC) including trastuzumab induces a high rate of pathological Complete Responses (pCR) in patients with locally advanced HER2-overexpressing Breast Cancer (BC), but is penalized by a severe cardiotoxicity when combined with anthracyclines. A phase II study was designed to assess whe...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-14-954
更新日期：2014-12-15 00:00:00
abstract：BACKGROUND:To report a case of metastatic hepatocholangiocarcinoma to the vitreous and retina. CASE PRESENTATION:A 70-year-old male, who was recently diagnosed with hepatocholangiocarcinoma, was complaining of floaters in his right eye over the past 5 months and was referred to the Liverpool Ocular Oncology Centre. On...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-017-3429-8
更新日期：2017-06-19 00:00:00
abstract：BACKGROUND:Immune checkpoint inhibitors (ICIs) were approved to have a significant antitumor activity in various tumor types. In practice, some patients do not seem to benefit from ICIs but rather to have accelerating disease. The aim of this study was to evaluate hyperprogression in patients with malignant tumors of d...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-019-5921-9
更新日期：2019-07-17 00:00:00
abstract：BACKGROUND:Kruppel family member zinc binding protein 89 (ZBP-89), also known as ZNF148, regulates Bak expression via binding to GC-rich promoter domain. It is not clear if other GC-rich binding factors, such as Sp family members, can interact with ZBPp-89 on Bak expression. This study aims to elucidate the mechanism o...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-018-4349-y
更新日期：2018-04-13 00:00:00
abstract：BACKGROUND:Carbonic anhydrase IX (CA IX) is a tumor-associated, highly active, transmembrane carbonic anhydrase isoform regulated by hypoxia and implicated in pH control and adhesion-migration-invasion. CA IX ectodomain (ECD) is shed from the tumor cell surface to serum/plasma of patients, where it can signify cancer p...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-016-2267-4
更新日期：2016-03-19 00:00:00
abstract：BACKGROUND:Prostate cancer displays different morphologies which, in turn, affect patient outcome. This fact prompted questions about the lineage relationship between differentiated, more treatable prostate adenocarcinoma and poorly differentiated, less treatable non-adenocarcinoma including small cell carcinoma, and t...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-019-5680-7
更新日期：2019-05-30 00:00:00
abstract：BACKGROUND:Neuroblastoma are pediatric tumors of the sympathetic nervous system with a poor prognosis. Apoptosis is often deregulated in cancer cells, but only a few defects in apoptotic routes have been identified in neuroblastoma. METHODS:Here we investigated genomic aberrations affecting genes of the intrinsic apop...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-12-285
更新日期：2012-07-12 00:00:00
abstract：BACKGROUND:Clinical interpretation of health related quality of life (HRQOL) scores is challenging. The purpose of this analysis was to interpret score changes and identify minimal clinically important differences (MCID) on the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Cor...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-13-165
更新日期：2013-03-28 00:00:00
abstract：BACKGROUND:HER2/neu overexpression is linked to promotion of angiogenesis in breast cancer. We therefore tested the activity of the combination of Trastuzumab with metronomic, low dose chemotherapy with cyclophosphamide (CTX) and methotrexate (MTX) in metastatic breast cancer (MBC). METHODS:Between April 2002 and June...
journal_title：BMC cancer
pub_type： 临床试验,杂志文章
doi：10.1186/1471-2407-6-225
更新日期：2006-09-15 00:00:00
abstract：BACKGROUND:The receptor tyrosine kinases (RTKs) play critical roles in the development of cancers. Clear cell renal cell carcinoma (ccRCC) accounts for 75% of the RCC. The previous studies on the RTKs in ccRCCs mainly focused on their gene expressions. The activation and function of the RTKs in ccRCC have not been full...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-019-6159-2
更新日期：2019-11-05 00:00:00
abstract：BACKGROUND:Vascular endothelial growth factor (VEGF) is a potent mitogen for endothelial cells, and its expression has been correlated with increased tumour angiogenesis. Although numerous publications dealing with the measurement of circulating VEGF for diagnostic and therapeutic monitoring have been published, the re...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-5-128
更新日期：2005-10-04 00:00:00
abstract：BACKGROUND:Budding is a complementary prognostic factor for colorectal cancer. In this study, we aimed to clarify the role of tumor budding in rectal cancer patients after preoperative chemoradiotherapy. METHODS:A total of 124 patients with rectal cancer treated with neoadjuvant chemoradiotherapy and consecutive surge...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-019-6261-5
更新日期：2019-11-01 00:00:00
abstract：BACKGROUND:The aim of this study was to assess the severity of pain and its impact on the quality of life (QoL) in untreated patients with head and neck squamous cell carcinoma (HNSCC). METHODS:A study group of 127 patients with HNSCC were interviewed before antineoplastic treatment. The severity of pain was measured ...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-14-39
更新日期：2014-01-24 00:00:00
abstract：BACKGROUND:Interpretation of comparative health-related quality of life (HRQOL) studies following different prostate cancer treatments is often difficult due to differing patient ages. Furthermore, age-related changes can hardly be discriminated from therapy-related changes. The evaluation of age-and comorbidity-relate...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-9-296
更新日期：2009-08-24 00:00:00
abstract：BACKGROUND:Many studies have reported the prognostic significance of the bone scan index (BSI) for metastatic castration-resistant prostate cancer (mCRPC); however, these reports are controversial. This study investigated the BSI in mCRPC and its relationship with prognosis. METHODS:The PubMed, Cochrane, and Embase da...
journal_title：BMC cancer
pub_type： 杂志文章,meta分析
doi：10.1186/s12885-020-06739-y
更新日期：2020-03-20 00:00:00
abstract：BACKGROUND:Breast cancer incidence varies between social groups, but differences have not been thoroughly examined in New Zealand. The objectives of this study are to determine whether trends in breast cancer incidence varied by ethnicity and socioeconomic position between 1981 and 2004 in New Zealand, and to assess po...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/1471-2407-10-674
更新日期：2010-12-07 00:00:00
abstract：BACKGROUND:Alcohol consumption is associated with increased risk of breast cancer (BC), and the underlying mechanism is thought to be sex-hormone driven. In vitro and observational studies suggest a mechanism involving peroxisome proliferator-activated receptor gamma (PPARγ) in a complex with peroxisome proliferator-ac...
journal_title：BMC cancer
pub_type： 杂志文章,随机对照试验
doi：10.1186/s12885-016-2317-y
更新日期：2016-04-21 00:00:00
abstract：BACKGROUND:Early life social environment may influence breast cancer through shaping risk factors operating in early life, adolescence and adulthood, or may be associated with breast cancer risk independent of known risk factors. We investigated the associations between early life socioeconomic status (SES) and mammogr...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-016-3010-x
更新日期：2017-01-10 00:00:00
abstract：OBJECTIVE:Crizotinib can target against mesenchymal-epithelial transition (MET) and anaplastic lymphoma kinase (ALK), which has been considered as a multi-targeted tyrosine kinase inhibitor (TKI). The objective of this study was to explore the efficacy of crizotinib in advanced non-small-cell lung cancer (NSCLC) with c...
journal_title：BMC cancer
pub_type： 杂志文章
doi：10.1186/s12885-018-5078-y
更新日期：2018-11-26 00:00:00
